Hyperglycemia in type II diabetes is known to compromise host defense against cutaneous infections by impairing wound healing, antimicrobial peptide (LL-37)(cathelicidin) production, and epithelial cell proliferation following tissue injury [15], [46], [47]. Here, CAMP is linked to type 2 diabetes mellitus.